Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
NEO-MINDSET: Aspirin Withdrawal Post-PCI Fails to Show Noninferiority for Ischaemic Events
Added: 5 months ago Source:  Radcliffe Cardiology
Early withdrawal of aspirin in favour of potent P2Y12 inhibitor monotherapy following percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) did not meet the criteria for noninferiority regarding ischaemic events compared to standard dual antiplatelet therapy (DAPT), according to the results of the NEO-MINDSET trial.¹ The strategy did, however, demonstrate superiority in… View more

Anticoagulation

Guidelines & Statements
Ticagrelor vs Clopidogrel Post-PCI: TADCLOT Results
Added: 2 months ago Source:  Radcliffe Cardiology
The first month following primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is a period of high risk for major adverse cardiovascular events (MACEs). The TADCLOT trial aimed to compare the efficacy of ticagrelor against a twice-daily clopidogrel regimen in this critical short-term window.¹The TADCLOT (Twice-A-Day CLOpidogrel vs Ticagrelor)… View more

Anticoagulation

Intervention
Author(s): Billy A Caceres Added: 2 years ago
Dr Billy A Caceres (Columbia University School of Nursing, US), a renowned expert and lead author, recently discussed findings from the study titled "Differences in Ideal Cardiovascular Health Between Sexual Minority and Heterosexual Adults" published in JAMA Cardiology. The study aimed to determine whether there are disparities in cumulative cardiovascular health (CVH) scores between sexual… View more

Demographic
Metabolic Surgery Superior to GLP-1 RAs for Long-Term Outcomes in Patients with Diabetes and Obesity
Added: 4 months ago Source:  Radcliffe CVRM
While both metabolic surgery and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are known to improve cardiometabolic health, direct long-term comparisons of their macrovascular and microvascular outcomes have been lacking. A new study published in Nature Medicine has addressed this gap by comparing these two major treatment strategies in patients with type 2 diabetes and obesity.¹This… View more

Cardiovascular Renal Metabolic

Intervention
Shortened Dual Antiplatelet Therapy
Author(s): Kevin S Tang , Shoujit Banerjee , George Tang , et al Added: 2 years ago

Anticoagulation

Intervention
IVUS123 workflow for PCI
Author(s): Simon J Walsh , Rafael Cavalcante , Kevin Croce , et al Added: 2 weeks ago

Guidelines & Statements

Intervention
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 5 months ago

Intervention

Prevention & Chronic Conditions
OCT Analysis Links Cardiovascular Risk Factor Burden to Plaque Vulnerability in ACS
Added: 6 months ago Source:  Radcliffe Cardiology
AUTHOR: Sean DelaneyA greater number of traditional cardiovascular risk factors is strongly associated with increased coronary plaque vulnerability in patients with acute coronary syndrome (ACS), particularly in culprit lesions, according to a new analysis published in JACC.¹ The study provides a direct morphological link between the cumulative burden of risk factors and the high-risk plaque… View more

Imaging & Diagnostics

Intervention
Drug-coated Balloon Angioplasty in Sri Lanka
Author(s): Yanushka Herath , Judy Ranaweera , Thisal Semina , et al Added: 2 months ago

Intervention

Prevention & Chronic Conditions